ChemSpider 2D Image | UU8815400 | C17H19FN2O7S

UU8815400

  • Molecular FormulaC17H19FN2O7S
  • Average mass414.405 Da
  • Monoisotopic mass414.089691 Da
  • ChemSpider ID5293439

  • defined stereocentres - 1 of 1 defined stereocentres

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(3S)-10-(1-Aminocyclopropyl)-9-fluor-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]chinolin-6-carbonsäure -methansulfonsäure (1:1) [German] [ACD/IUPAC Name]
(3S)-10-(1-Aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid methanesulfonate
(3S)-10-(1-Aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid methanesulfonate (1:1) [ACD/IUPAC Name]
163680-77-1 [RN]
2ξ226J1HS
7H-1,4-Oxazino[2,3,4-ij]quinoline-6-carboxylic acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-, methanesulfonate (1:1) [ACD/Index Name]
Acide (3S)-10-(1-aminocyclopropyl)-9-fluoro-3-méthyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoléine-6-carboxylique - acide méthanesulfonique (1:1) [French] [ACD/IUPAC Name]
MFCD00913262 [MDL number]
Pazufloxacin (mesylate)
pazufloxacin mesilate
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

T 3762 [DBID]
GM-1172 [DBID]
T-3762 [DBID]
  • Experimental Physico-chemical Properties
  • Predicted Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      Antibacterial MedChem Express HY-B0724A
      Anti-infection MedChem Express HY-B0724A
      Anti-infection; MedChem Express HY-B0724A
      Pazufloxacin (T-3761) mesylate is a fluoroquinolone antibiotic. MedChem Express
      Pazufloxacin (T-3761) mesylate is a fluoroquinolone antibiotic.; Target: Antibacterial; Pazufloxacin (T-3761), a new quinolone derivative, showed broad and potent antibacterial activity. MedChem Express HY-B0724A
      Pazufloxacin (T-3761) mesylate is a fluoroquinolone antibiotic.;Target: AntibacterialPazufloxacin (T-3761), a new quinolone derivative, showed broad and potent antibacterial activity. T-3761 showed good efficacy in mice against systemic, pulmonary, and urinary tract infections with gram-positive and gram-negative bacteria, including quinolone-resistant Serratia marcescens and Pseudomonas aeruginosa. The in vivo activity of T-3761 was comparable to or greater than those of ofloxacin, ciprofloxacin, norfloxacin, and tosufloxacin against most infection models in mice. The activities of T-3761 were lower than those of tosufloxacin against gram-positive bacterial systemic and pulmonary infections in mice but not against infections with methicillin-resistant Staphylococcus aureus [1]. T-3761 had a broad spectrum of activity and had potent activity against gram-positive and -negative bacteria. The MICs of T-3761 against 90% of the methicillin-susceptible Staphylococcus aureus, methicillin MedChem Express HY-B0724A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement